… The vast majority of thyroid cancers originate from follicular epithelial cells, which are … as
papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), and anaplastic thyroid cancer (…

… staging, alone or in combination with BRAF V600E , is emerging as a useful tool in refining
the prognostic classification of DTC patients. It is likely that in the near future, the TNM …

… prognostic factors associated with PTC prognosis, … in thyroid cancer cells. Furthermore, it
was observed that in tissue samples obtained from patients with papillary thyroid carcinoma, the …

… miRNA evaluation is a promising tool in the discovery of novel diagnostic and prognostic
PTC biomarkers. In recent years, genetic determination has become one of the most rapidly …

… Clearly the evidence implicating p16 as both a diagnostic and prognostic tool in thyroid
cancer is promising, but the mechanisms that underlie these observations are yet to be fully …

… It is most likely that a complex “molecular signature” will one day more precisely identify
aggressive PTC, but at present BRAF is the marker with the greatest prognostic utility. …

… The prognostic utility of these two systems converges when additional demographic and
clinical factors are considered. AJCC staging was found to classify patients across a wider …

… thyroid neoplastic transformation in the context of their relationship to thyroid cancer prognosis.
… other than BRAF that are known to have prognostic utility in DTC. Lastly, we present the …

… Our aim in this investigation is to gain insight into the potential clinical utility of IRGs on
prognostic stratification and their implicational potential as biomarkers for targeted PTC therapy. …

… Papillary thyroid carcinoma (PTC) with BRAF mutation carries a poorer prognosis. Prophylactic
central neck dissection (CND) reduces locoregional recurrences, and we hypothesize …